(Q48733781)

English

W ay 100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT 1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor

scientific article published on April 1, 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

W ay 100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT 1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor (English)

1 reference

10.1016/S0028-3908(97)00050-6

https://api.crossref.org/works/10.1016/S0028-3908(97)00050-6

7 November 2024

author name string

S. Hjorth

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9225270

7 November 2024

D. Westlin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9225270

7 November 2024

H. J. Bengtsson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9225270

7 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9225270

7 November 2024

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

April 1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9225270

7 November 2024

number of pages

5

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0028390897000506?httpAccept=text/xml

1 reference

10.1016/S0028-3908(97)00050-6

https://api.crossref.org/works/10.1016/S0028-3908(97)00050-6

7 November 2024

https://api.elsevier.com/content/article/PII:S0028390897000506?httpAccept=text/plain

1 reference

10.1016/S0028-3908(97)00050-6

https://api.crossref.org/works/10.1016/S0028-3908(97)00050-6

7 November 2024

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

36

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

4-5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

461-465

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Autoreceptor Antagonists Enhance the Effect of the Reuptake Inhibitor Citalopram on Extracellular 5-HT: this Effect Persists After Repeated Citalopram Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900050-6

7 January 2021

WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135

11

1 reference

10.1016/S0028-3908(97)00050-6

https://api.crossref.org/works/10.1016/S0028-3908(97)00050-6

7 November 2024

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study

28

1 reference

10.1016/S0028-3908(97)00050-6

https://api.crossref.org/works/10.1016/S0028-3908(97)00050-6

7 November 2024

Identifiers

10.1016/S0028-3908(97)00050-6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9225270

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48733781&oldid=2271441539"